Angina Drugs Flashcards

1
Q

Angina is caused by what?

A

CORONARY ISCHAEMIA which is the result of atherosclerosis by
Sudden ischemia is usually caused by
thrombosis and may result in infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

-. Ca2+ overload results from

A

from ischemia
May be responsible for cell death, arrhythmias, diastolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ANGINA occurs when

A

the oxygen supply to the myocardium is insufficient for its needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Three types of angina

A

1)Stable: predictable chest pain on exertion
Produced by increased demand on the heart usually caused by atheroma of coronary vessels or aortic stenosis
2) Unstable angina: pain that occurs with less and less exertion, culminating in pain at rest
Pathology is similar to myocardial infarction (MI)
but without complete occlusion of the vessel
3) Variant angina: relatively uncommon
Occurs at rest
Caused by coronary artery spasm, often in
association with atheromatous disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TREATMENT APPROACH for angina
(inc./dec.)

A

•Decrease oxygen requirements
-Decrease total peripheral resistance (TPR)
-Decrease cardiac output (CO)
-Nitrates, calcium channel blockers (CCBs), beta-blockers

● Increase oxygen delivery
-Coronary artery vasodilation
-Opposes coronary spasm in variant angina -Nitrates and CCBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment for underlying atheromatous
disease

A

-Statins
-Prophylaxis against thrombosis with
antiplatelet drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BETA-BLOCKERS MoA

A

-SNS stimulation increases CO
Ventricle:
● Increased force of contraction
● Increased SV

SA and AV node: increases HR

-Reduce cardiac work and thus oxygen consumption of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BETA BLOCKERS Clinical Use:

A

Clinical Use: Prophylaxis of stable angina (first- line) and treatment of unstable angina

Coronary diameter effects should be minor
Avoided in variant angina due to theoretical risk of
increasing coronary spasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

an alternative for patients that cannot use beta-blockers

A

Ivabradine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Three main L-type CCBs
For angina

A

Verapamil (heart)
Diltiazem (heart and smooth muscle vasculature)
Nifedipine (smooth muscle vasculature)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do CCBs do in angina

A

•Dilate coronary vessels (effect on smooth muscle
vasculature)
•Decrease metabolic demands (effect on TPR and heart)= DECREASES TPR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nitrates examples

A

•Glyceryl trinitrate (GTN): acute HF
•Isosorbide mononitrate: chronic HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical Use
Of CCBs

A

May be used in combination with beta-blockers (dihydropyridines;CCB), when monotherapy is insufficient, or as alternative in stable angina

Dihydropyridines: vasospastic angina
(DIHYDROPYRIDINES= vasodilation drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Therapeutic goal in angina
Of NITRATES

A

Improve perfusion of the myocardium
Reduce metabolic demands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NITRATES: MOA

A

•Venorelaxation -> central venous pressure (CVP) reduction i.e. reduced preload, reduced SV
•Effects on arteries: reduce afterload
-Myocardial oxygen consumption falls due to reduced afteload and preload
•Direct coronary vessel dilation increases oxygen content in coronary sinus blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADVERSE EFFECTS
Of nitrates

A

•(You build) Tolerance: d/t Depletion of –SH groups
Tolerance wears off after a brief nitrate-free interval
•Pronounced with long-acting nitrates or prolonged/frequent administration (IV infusion, transdermal patch)
•Postural hypotension- Contraindicated in hypotension
•Headache
•Reflex tachycardia

17
Q

NITRATES
Clinical use in angina

A

•Stable: May be used in combination with beta-
blockers/CCBs
•Variant: May be used in combination with CCBs
•Unstable: In combination with other drugs e.g. anti-platelets

18
Q

Nicorandil MoA
+ Adverse effects

A

•Potassium channel activator with nitrovasodilator activity
•Sometimes combined with other anti-anginal treatments in refractory angina resistant cases
•Both arterial and venous dilator
Adverse effects: headache, flushing, dizziness, hypotension

19
Q

POTASSIUM CHANNEL ACTIVATION
Works how

A

•Relax smooth muscle
-Open KATP channels
-Hyperpolarization
-Switching off of VDCC

•Antagonize the action of intracellular ATP on these channels

20
Q

RANOLAZINE MOA

A

-Ischemia causes increased Na+
-Prevents Ca2+ exit via Na+/Ca2+ exchanger (NCX)
!-Ranolazine inhibits late sodium current
!-Indirectly reduces intracellular Ca2+
!-Decreased EDP and thus improvement of diastolic coronary flow

21
Q

Ranolazine Adverse effects

A

-Adjunct to other anti-anginal drugs

•Adverse effects: constipation, headache, dizziness, nausea, increased QT interval

-!Does not reduce blood pressure or heart rate

22
Q

Ranolazine CI

A

Contraindicated in long QT syndrome or drugs which prolong the QT interval
Anti-psychotics, class Ia & III anti-arrhythmic drugs
Ex. Haloperidol

23
Q

Stable angina: first-line+ alternative/ combination therapy

A

1.Beta blocker
2. CCB / long acting nitrates

24
Q

Unstable angina tx

A

Anticoagulation, antiplatelets, β-blockers, ACE inhibitors,
statins Symptom control: nitroglycerin and morphine

25
Q

Variant angina:
1, first line
2. Alternator monotherapy / in combo

A

1.CCB (e.g.
amlodipine, diltiazem)

2.Long-acting nitrates